Ontruzant, the first biosimilar version of Roche’s Herceptin (trastuzumab) in Europe has been launched in the UK by MSD. Developed by Korean biosimilar specialists Samsung Bioepsis, MSD is the ...

Developed by Samsung Bioepis, the FDA has approved the biosimilar, Ontruzant, ruling that the near-copy has no significant differences compared with the original drug in terms of safety and efficacy.